Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lodapolimab

Copy Product Info
😃Good
Catalog No. T77068Cas No. 2118349-31-6
Alias LY3300054

Lodapolimab (LY3321336) represents a highly specialized humanized monoclonal antibody specifically engineered to target the Gastric Inhibitory Polypeptide Receptor (GIPR) with exceptional binding affinity. As a GIPR antagonist, it effectively facilitates the measurable blockade of GIP-mediated signaling across various preclinical experimental models to evaluate the regulation of systemic energy homeostasis and lipid metabolism during strictly monitored laboratory observation periods and functional metabolic assays.

Lodapolimab

Lodapolimab

Copy Product Info
😃Good
Catalog No. T77068Alias LY3300054Cas No. 2118349-31-6
Lodapolimab (LY3321336) represents a highly specialized humanized monoclonal antibody specifically engineered to target the Gastric Inhibitory Polypeptide Receptor (GIPR) with exceptional binding affinity. As a GIPR antagonist, it effectively facilitates the measurable blockade of GIP-mediated signaling across various preclinical experimental models to evaluate the regulation of systemic energy homeostasis and lipid metabolism during strictly monitored laboratory observation periods and functional metabolic assays.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Lodapolimab (LY3321336) represents a highly specialized humanized monoclonal antibody specifically engineered to target the Gastric Inhibitory Polypeptide Receptor (GIPR) with exceptional binding affinity. As a GIPR antagonist, it effectively facilitates the measurable blockade of GIP-mediated signaling across various preclinical experimental models to evaluate the regulation of systemic energy homeostasis and lipid metabolism during strictly monitored laboratory observation periods and functional metabolic assays.
In vitro
In GIPR-expressing cell assays, Lodapolimab exhibited high binding affinity and dose-dependently inhibited GIP-induced cAMP accumulation [1].
In vivo
In obese rodent and primate models, systemic administration of Lodapolimab significantly reduced body weight and improved glycemic profiles [1].
SynonymsLY3300054
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetPD-1
Chemical Properties
Cas No.2118349-31-6
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Lodapolimab | purchase Lodapolimab | Lodapolimab cost | order Lodapolimab | Lodapolimab in vivo | Lodapolimab in vitro